Singapore researchers discover omega-3 lipid's potential to combat fatty liver disease.

Research from Duke-NUS Medical School reveals the omega-3 transporter protein, Mfsd2a, can prevent excessive liver fat storage, offering potential prevention against non-alcoholic fatty liver disease (NAFLD). The key lies in phospholipids, especially those containing omega-3 fatty acid DHA. The team aims to validate these findings through rigorous clinical trials.